Quarterly Report • May 15, 2025
Quarterly Report
Open in ViewerOpens in native device viewer




| in million EUR | 01/01-31/03/2025 | % | 01/01-31/03/2024 | % |
|---|---|---|---|---|
| Germany | 22.5 | 32.0 | 18.6 | 36.8 |
| Rest of Europe | 17.7 | 25.1 | 10.7 | 21.2 |
| North America | 26.3 | 37.4 | 16.9 | 33.5 |
| Other countries (Australia, UAE) | 3.9 | 5.5 | 4.3 | 8.5 |
| Total | 70.4 | 100.0 | 50.5 | 100.0 |
Revenues based on customer's location.
Gross profit amounted to EUR 23.5m and is well above previous year's figure (Q1 2024: EUR 17.9m). At around 33 per cent, the gross margin has decreased compared to previous year (Q1 2024: around 35 per cent). This is mainly due to the business mix with a higher portion of large-scale projects, particularly in North America. In addition, effects from underutilisation of smaller entities had an impact on gross profit.
Sales and administrative expenses have increased by EUR 4.4m to EUR 17.1m compared to the previous year (Q1 2024: EUR 12.6m). About one third of the increase is caused by the consideration of the DILAX group. The additional costs are due to increased headcount, especially in sales, and to salary adjustments made in the previous year.
In total research and development expenses have increased to EUR 7.4m (previous year: EUR 5.3m), including the services for internally developed software of EUR 2.8m (previous year: EUR 2.2m) which were capitalised in line with the 2024 financial statements. Expenses of EUR 4.6m were recognised in the income statement (Q1 2024: EUR 3.1m). Thereof EUR 0.7m are contributed by DILAX group consolidated for the first time.
Foreign exchange losses increased in the reporting period (EUR 0.5m; previous year: foreign exchange gains EUR 0.8m). This position mainly includes unrealized gains and losses on the valuation of receivables and liabilities in foreign currencies, primarily in relation to the US Dollar.
Earnings before interest and taxes (EBIT) of EUR 2.0m was below the previous year's figure (Q1 2024: EUR 3.7m). In addition to the expected negative contribution from the DILAX group in the quarter, this is due to the developments described above. Main drivers are the under-proportional development of gross profit, the unfavourable foreign exchange results and the increase in research and development expenses.
Net interest income (balance of interest income and interest expense) amounted to EUR -0.7m and was below previous year's level (Q1 2024: EUR -0.3m). The increase is mainly caused by financing the acquisition of the DILAX group.
Consolidated net profit amounted to EUR 1.4m as of 31 March 2025 and is below the previous year's figure, mainly due to the lower operating earnings (Q1 2024: EUR 2.3m). Earnings per share amount to EUR 0.16 (Q1 2024: EUR 0.24).
Total comprehensive income amounted to EUR -0.6m (Q1 2024: EUR 3.5m). The decrease is a result of the lower consolidated net profit as well as from losses from currency translation.
Cash flow from operating activities amounted to EUR 15.5m (Q1 2024: EUR 7.5m) and was significantly higher than the previous year's figure. This was mainly due to a positive contribution from working capital items – primarily from an increase in contract liabilities as a result of the expected payments of large-scale projects in North America.

| 31/03/2025 | 31/03/2024 | |
|---|---|---|
| Germany | 1,188 | 970 |
| Rest of Europe | 148 | 98 |
| North America | 172 | 152 |
| Other countries | 27 | 24 |
| Total | 1,535 | 1,244 |


| 01/01 to | 01/01 to | |
|---|---|---|
| 31/03/2025 | 31/03/2024 | |
| EUR '000 | ||
| Revenues | 70,407 | 50,453 |
| Cost of sales | -46,878 | -32,549 |
| Gross profit | 23,529 | 17,904 |
| Sales and marketing expenses | -8,443 | -6,838 |
| General administrative expense | -8,619 | -5,810 |
| Research and development expenses | -4,608 | -3,063 |
| Other operating income | 792 | 840 |
| Other operating expenses | -157 | -109 |
| Foreign currency gains and losses | -503 | 755 |
| Earnings before interest and taxes (EBIT) | 1,991 | 3,679 |
| Interest income | 77 | 156 |
| Interest expenses | -741 | -485 |
| Earnings before taxes (EBT) | 1,327 | 3,350 |
| Income taxes | 51 | -1,032 |
| Net profit | 1,378 | 2,318 |
| thereof attributable to equity holders of parent company | 1,563 | 2,402 |
| thereof non-controlling interests | -185 | -84 |
| Earnings and diluted earnings per share in EUR | 0.16 | 0.24 |
| Average number of floating shares | 9,881,804 | 9,844,993 |
| EUR '000 | 01/01 to 31/03/2025 | 01/01/ bis 31/03/2024 |
|---|---|---|
| Net profit | 1,378 | 2,318 |
| Items to be reclassified to the income statement: | ||
| Net gains (+) / net losses (-) on currency translation | -1,991 | 1,174 |
| Total other comprehensive income | -1,991 | 1,174 |
| Total comprehensive income | -613 | 3,492 |
| Thereof attributable to equity holders of the parent company | -428 | 3,576 |
| Thereof non-controlling interests | -185 | -84 |

| EUR '000 | 31/03/2025 | 31/03/2024 | 31/12/2024 |
|---|---|---|---|
| Cash and cash equivalents | 26,058 | 39,108 | 23,523 |
| Marketable securities and bonds | 27 | 28 | 30 |
| Trade accounts receivable | 48,690 | 32,774 | 47,803 |
| Future receivables from production orders from PoC method | 43,952 | 28,558 | 39,929 |
| Receivables from related parties | 3 | 29 | 40 |
| Inventories | 54,974 | 54,271 | 57,213 |
| Income tax receivable | 2,183 | 0 | 2,753 |
| Other assets | 8,087 | 5,263 | 6,674 |
| Current assets, total | 183,974 | 160,031 | 177,965 |
| 0 | |||
| Property, plant and equipment | 69,594 | 66,932 | 70,912 |
| Investment property | 1,122 | 1,349 | 1,124 |
| Goodwill | 13,326 | 12,488 | 13,326 |
| Other intangible assets | 45,528 | 26,844 | 44,105 |
| Interests in associated companies | 929 | 778 | 929 |
| Deferred tax assets | 3,622 | 4,738 | 2,538 |
| Other assets | 2,198 | 3,783 | 2,133 |
| Non-current assets, total | 136,319 | 116,912 | 135,067 |
| Assets, total | 320,293 | 276,943 | 313,032 |
| Bank loans | 34,445 | 29,722 | 39,418 |
| Trade accounts payable | 9,148 | 8,138 | 13,580 |
| Accounts payable from PoC method | 36,660 | 20,790 | 20,392 |
| Advance payments received | 5,312 | 5,233 | 1,597 |
| Income tax payable | 1,467 | 2,404 | 3,615 |
| Provisions | 3,853 | 4,191 | 4,319 |
| Lease liabilities | 5,232 | 4,095 | 5,020 |
| Other liabilities | 21,600 | 15,784 | 19,661 |
| Current liabilities, total | 117,717 | 90,357 | 107,602 |
| Bank loans | 28,151 | 23,479 | 29,973 |
| Deferred tax liabilities | 8,120 | 6,383 | 7,440 |
| Pensions accrued and similar obligations | 7,806 | 7,787 | 7,807 |
| Provisions | 1,938 | 1,679 | 1,748 |
| Lease liabilities | 23,210 | 23,174 | 24,150 |
| Non-current liabilities, total | 69,225 | 62,502 | 71,118 |
| Liabilities, total | 186,942 | 152,859 | 178,720 |
| Attributable to equity holders of the parent company | |||
| Subscribed capital | 10,040 | 10,040 | 10,040 |
| Additional paid-in capital | 6,144 | 5,949 | 7,734 |
| Treasury stock | -2,262 | -4,463 | -4,463 |
| Surplus reserves and consolidated unappropriated profit | 116,401 | 108,539 | 115,798 |
| Other reserves | 3,086 | 3,694 | 5,076 |
| 133,409 | 123,759 | 134,185 | |
| Non-controlling interests | -58 | 325 | 127 |
| Shareholders' equity, total | 133,351 | 124,084 | 134,312 |
| Liabilities and shareholders' equity, total | 320,293 | 276,943 | 313,032 |

| EUR '000 | 01/01 to 31/03/2025 01/01 to 31/03/2024 | |
|---|---|---|
| Cash flow from operating activities | ||
| Net income | 1,378 | 2,318 |
| Amortisation and depreciation | 4,032 | 2,963 |
| Gains on the disposal of fixed assets | -80 | 6 |
| Change in provisions and accruals | -232 | 286 |
| Change in inventories | 1,412 | -4,686 |
| Change in trade accounts receivable and future receivables from production orders | -6,550 | 4,567 |
| Change in other assets, not provided by / used in investing or financing activities | -1,023 | 821 |
| Change in trade accounts payable | -4,097 | -4,267 |
| Change in advanced payments received and liabilities from PoC method | 20,794 | 6,369 |
| Change in other liabilities, not provided by / used in investing or financing activities | 446 | -1,604 |
| Amount of other non-cash income and expenses | -537 | 730 |
| Net cash from operating activities | 15,543 | 7,503 |
| Cash flow from investing activities | ||
| Payments received on disposal of property, plant and equipment | 96 | 46 |
| Investments in property, plant and equipment | -1,265 | -484 |
| Investments in other intangible assets | -2,898 | -2,194 |
| Cash paid/received for financial assets | 0 | 9 |
| Payments received on disposal of marketable securities | 2 | 2 |
| Capital contributions and loans to associated companies | 0 | -1 |
| Net cash flows used in investing activities | -4,065 | -2,622 |
| Cash flow from financing activities | ||
| Payments received from bank loans incurred | 7,603 | 10,728 |
| Redemption of bank loans | -14,397 | -2,871 |
| Payment of principal on lease liabilities | -1,267 | -1,015 |
| Change in current and non-current lease liabilities | -129 | -86 |
| Net cash flows used in financing activities | -8,190 | 6,756 |
| Net effects of currency translation and | ||
| consolidation changes in cash and cash equivalents | -753 | 168 |
| Changes in cash and cash equivalents | 2,535 | 11,805 |
| Cash and cash equivalents at the beginning of the period | 23,523 | 27,303 |
| Cash and cash equivalents at the end of the period | 26,058 | 39,108 |

init innovation in traffic systems SE Kaeppelestrasse 4-10 76131 Karlsruhe
Germany
PO Box 3380 76019 Karlsruhe
Germany
Ph.+49.721.6100.0 Fax +49 721 6100 399
www.initse.com
This distribution of our report does not represent and is not intended as an offer for trade in shares.
This report contains future-related statements, which are based on current estimates of the company with regard to future developments. Such statements are inherently subject to risks and un-certainties, as they may be affected by factors that are neither controllable nor foreseeable by init, such as on the development of the future market environment and economic conditions, the behaviour of other market participants and government measures. If one of these uncontrollable or unforeseeable factors occurs respectively changes or the assumptions on which these statements are based prove inaccurate, actual developments and results could differ materially from the results cited explicitly or contained implicitly in these statements.

Q2 22 May
Q3 14 August
Publication Half-year Financial Report 2025
Shareholders' Meeting 2025 in Karlsruhe
Q4 13 November
Publication Quarterly Statement 3/2025
24-25 November
Equity Forum
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.